Warhound Raises $200M for Genetic Dogs

A new company founded by Palmer Luckey has secured $200 million to develop genetically modified dogs for the armed forces. Warhound stated that its animals will detect explosives and provide protection for troops. The funding round included investment from Sequoia. Colossal Biosciences is assisting with the cloning and gene-editing processes.

The startup emerged from the intersection of consumer tech and defense contracting. Luckey previously founded Oculus. The new venture aims to apply biotechnology to traditional military roles. Investors have backed the $200 million effort to integrate biological engineering with defense strategy.

The company plans to use these enhanced animals in field operations. The specific genetic modifications will target sensory capabilities. This approach differs from standard breeding programs. It relies on precise editing of the canine genome.

The funding was announced on October 23, 2026. This follows a trend of private companies entering the defense sector. The money will support research and development. It will also cover the costs of initial trials.

Warhound is not the only entity working in this space. Other biotech firms are exploring similar applications for service animals. The military has long relied on dogs for detection work. This new model seeks to upgrade those capabilities through technology.

The partnership with Colossal Biosciences brings specialized cloning expertise to the project. This collaboration aims to accelerate the timeline for producing viable subjects. The goal is to deploy these animals in operational settings. The $200 million investment signals confidence in the commercial and military potential of the technology.